Aphria (APHA)

Company Profile

Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini in 2013 and is headquartered in Leamington, Canada.

Company profile

Ticker

APHA

Exchange

NASDAQ

Website

aphriainc.com/

CEO

Irwin Simon

Incorporated

Alberta, Canada

Location

Ontario, Canada

Fiscal year end

May 31

Sector

Manufacturing > Medicinal and Botanical Manufacturing

Industry (SIC)

Medicinal Chemicals & Botanical Products

Jushi • Ascend Wellness • Trulieve Cannabis • Usana Health Sciences • 4Front Ventures • SNDL • Mind Medicine • Glass House Brands • C21 Investments • Tilray Brands ...

SEC CIK

0001733418

APHA stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

15-12B

Securities registration termination

11 May 21

S-3ASR

Automatic shelf registration

6 May 21

6-K

Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader

4 May 21

F-10POS

Automatic registration of securities (post-effective amendment, Canada)

Good Supply Expands Product Portfolio With the Introduction of Hash, Wax, and Kief

29 Apr 21

6-K

Broken Coast Enters the Concentrates Category by Adding Wax to its Product Offerings

26 Apr 21

6-K

Current report (foreign)

26 Apr 21

6-K

Aphria Inc.'s Adult-Use Brands Good Supply and Solei Introduce High Potency Oils to its Product Lineup

15 Apr 21

6-K

Current report (foreign)

15 Apr 21

Transcripts

APHA

Earnings call transcript

2021 Q3

12 Apr 21

APHA

Earnings call transcript

2021 Q2

14 Jan 21

APHA

Earnings call transcript

2021 Q1

15 Oct 20

Latest ownership filings

SC 13G

Scythian Biosciences Corp.

5 Mar 18

Financial summary

Financial statements Chart APHA financial data

Annual (USD)	May 20	May 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Aphria earnings reports.

Institutional ownership, Q1 2022

APHA institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1	0	NEW
Opened positions	1	0	NEW
Closed positions	0	1	EXIT
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	8.00 k	0.00	NEW
Total shares	421.00	0.00	NEW
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
N.E.W. Advisory Services	421.00	$8.00 k	NEW

Largest transactions	Shares	Bought/sold	Change
N.E.W. Advisory Services	421.00	+421.00	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.